- $1.17bn
- $1.13bn
- $399.25m
- 82
- 42
- 38
- 53
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 231 | 207 | 274 | 330 | 399 |
Cost of Revenue | |||||
Gross Profit | 170 | 149 | 206 | 246 | 300 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 264 | 251 | 219 | 373 | 426 |
Operating Profit | -33.1 | -44.2 | 55.2 | -42.7 | -26.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -35 | -48 | 50.4 | -46.2 | -29.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -35.2 | -48.2 | 50.2 | -46.5 | -30.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -35.2 | -48.2 | 50.2 | -46.5 | -30.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -35.2 | -48.2 | 50.2 | -46.5 | -30.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.868 | -1.08 | 2.87 | -1.02 | -0.657 |